Stock data
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX) reported revenue of US$1.54M and net income of -US$258.76M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.54M | — | -US$287.37M | -US$258.76M | — |
| 2024 | US$7.02M | — | -US$195.08M | -US$157.86M | — |
| 2023 | US$6.88M | — | -US$154.54M | -US$141.43M | — |
| 2022 | US$2.36M | — | -US$115.23M | — | — |
| 2021 | US$4.65M | — | -US$71.24M | — | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.02M | -US$73.50M | — |
| 2026-03-31 | US$0.01M | -US$78.69M | — |
| 2025-12-31 | — | -US$81.32M | — |
| 2025-09-30 | — | -US$67.04M | — |
| 2025-06-30 | US$0.73M | -US$56.60M | — |
| 2025-03-31 | US$0.69M | -US$53.80M | — |
| 2024-12-31 | US$1.18M | -US$47.09M | — |
| 2024-09-30 | US$3.19M | -US$42.12M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.